Synergistic drug combination of active S-ketamine enantiomers with gabprena for the treatment of neuropathic pain

摘要

The invention refers to a pharmaceutical component, which includes a synergistic action of ainai, which is an active component: S-ketamine and a base ratio derivative, which is an active component: gabaprina, They are made from a single dose unit of pharmaceutically acceptable precursor chemicals, managed by oral, parenting, poisoning, skin dialysis or oral inhalation devices, nose. It is also suitable for the treatment of nerve and / or harmful pain caused by various causes.